AAPL349.52+5.69 (+1.65%) ▲|ABBV291.18+5.19 (+1.81%) ▲|ABT103.62+0.98 (+0.95%) ▲|ACN243.66+0.26 (+0.10%) ▲|ADBE247.70-2.06 (-0.82%) ▼|AMAT416.25+0.25 (+0.06%) ▲|AMD568.12-10.32 (-1.78%) ▼|AMGN465.24+13.41 (+2.97%) ▲|AMT185.10+1.35 (+0.73%) ▲|AMZN246.26-8.34 (-3.28%) ▼|AVGO342.50-9.32 (-2.65%) ▼|AXP325.34+7.40 (+2.33%) ▲|BA170.33+3.19 (+1.91%) ▲|BAC51.76+0.91 (+1.78%) ▲|BKNG151.34+3.40 (+2.30%) ▲|BLK1,175.81+17.93 (+1.55%) ▲|BMY60.30-0.27 (-0.45%) ▼|BNY149.42+0.83 (+0.56%) ▲|BRK-B544.87+4.53 (+0.84%) ▲|C126.14+2.03 (+1.64%) ▲|CAT660.01-53.38 (-7.48%) ▼|CL91.89+0.20 (+0.21%) ▲|CMCSA21.82+0.25 (+1.16%) ▲|COF208.56+3.68 (+1.80%) ▲|COP149.82+0.76 (+0.51%) ▲|COST986.49+3.76 (+0.38%) ▲|CRM232.91-9.20 (-3.80%) ▼|CSCO109.78-0.51 (-0.46%) ▼|CVS91.12+1.17 (+1.30%) ▲|CVX231.09+1.89 (+0.82%) ▲|DE642.73+2.06 (+0.32%) ▲|DHR235.33+1.26 (+0.54%) ▲|DIS110.41+1.37 (+1.26%) ▲|DUK125.00+1.43 (+1.16%) ▲|EMR169.24+1.53 (+0.91%) ▲|FDX302.21-2.37 (-0.78%) ▼|GD366.11+11.76 (+3.32%) ▲|GE310.12+8.99 (+2.99%) ▲|GEV910.54+32.51 (+3.70%) ▲|GILD162.32+3.12 (+1.96%) ▲|GM83.90+1.42 (+1.72%) ▲|GOOG283.34-38.55 (-11.98%) ▼|GOOGL285.45-39.44 (-12.14%) ▼|GS934.98+9.81 (+1.06%) ▲|HD324.25+6.69 (+2.11%) ▲|HON217.91-1.35 (-0.62%) ▼|IBM253.97+0.75 (+0.30%) ▲|INTC93.11-2.42 (-2.53%) ▼|INTU330.88+2.69 (+0.82%) ▲|ISRG445.80+1.62 (+0.36%) ▲|JNJ274.67+3.63 (+1.34%) ▲|JPM345.18+5.88 (+1.73%) ▲|KO92.45+0.72 (+0.78%) ▲|LIN502.00-6.16 (-1.21%) ▼|LLY1,384.73+96.43 (+7.48%) ▲|LMT642.53+12.78 (+2.03%) ▲|LOW203.16+4.76 (+2.40%) ▲|LRCX258.03+4.21 (+1.66%) ▲|MA638.11+27.80 (+4.55%) ▲|MCD254.90+4.40 (+1.75%) ▲|MDLZ62.04+0.17 (+0.27%) ▲|MDT95.35+0.57 (+0.60%) ▲|META623.57+11.08 (+1.81%) ▲|MMM175.54+2.74 (+1.59%) ▲|MO75.79+2.80 (+3.83%) ▲|MRK146.79+5.86 (+4.15%) ▲|MS192.41+2.28 (+1.20%) ▲|MSFT524.28-6.73 (-1.27%) ▼|MU955.79-27.44 (-2.79%) ▼|NEE81.88+0.86 (+1.06%) ▲|NFLX62.09+0.10 (+0.15%) ▲|NKE38.22+1.07 (+2.88%) ▲|NOW113.63-36.50 (-24.31%) ▼|NVDA213.78-1.60 (-0.74%) ▼|ORCL140.26-4.29 (-2.96%) ▼|PEP133.00+0.37 (+0.28%) ▲|PFE29.69+0.24 (+0.80%) ▲|PG158.87+0.61 (+0.39%) ▲|PLTR195.59-1.22 (-0.62%) ▼|PM205.45+2.81 (+1.39%) ▲|QCOM181.31-1.66 (-0.91%) ▼|RTX199.85+4.01 (+2.05%) ▲|SBUX104.98+1.78 (+1.72%) ▲|SCHW89.71+0.95 (+1.06%) ▲|SO92.70+1.18 (+1.29%) ▲|SPG214.63+3.39 (+1.60%) ▲|T20.70-0.24 (-1.15%) ▼|TMO704.94+0.79 (+0.11%) ▲|TMUS149.97+1.89 (+1.27%) ▲|TSLA403.77-0.45 (-0.11%) ▼|TXN309.83+0.92 (+0.30%) ▲|UBER65.27-0.51 (-0.78%) ▼|UNH407.10-3.29 (-0.80%) ▼|UNP297.80-2.08 (-0.69%) ▼|UPS105.62-0.47 (-0.44%) ▼|USB59.60-0.14 (-0.23%) ▼|V400.60-1.26 (-0.31%) ▼|VZ43.18-0.75 (-1.71%) ▼|WFC83.67+1.01 (+1.22%) ▲|WMT118.77-0.55 (-0.46%) ▼|XOM182.02+2.11 (+1.17%) ▲|AAPL349.52+5.69 (+1.65%) ▲|ABBV291.18+5.19 (+1.81%) ▲|ABT103.62+0.98 (+0.95%) ▲|ACN243.66+0.26 (+0.10%) ▲|ADBE247.70-2.06 (-0.82%) ▼|AMAT416.25+0.25 (+0.06%) ▲|AMD568.12-10.32 (-1.78%) ▼|AMGN465.24+13.41 (+2.97%) ▲|AMT185.10+1.35 (+0.73%) ▲|AMZN246.26-8.34 (-3.28%) ▼|AVGO342.50-9.32 (-2.65%) ▼|AXP325.34+7.40 (+2.33%) ▲|BA170.33+3.19 (+1.91%) ▲|BAC51.76+0.91 (+1.78%) ▲|BKNG151.34+3.40 (+2.30%) ▲|BLK1,175.81+17.93 (+1.55%) ▲|BMY60.30-0.27 (-0.45%) ▼|BNY149.42+0.83 (+0.56%) ▲|BRK-B544.87+4.53 (+0.84%) ▲|C126.14+2.03 (+1.64%) ▲|CAT660.01-53.38 (-7.48%) ▼|CL91.89+0.20 (+0.21%) ▲|CMCSA21.82+0.25 (+1.16%) ▲|COF208.56+3.68 (+1.80%) ▲|COP149.82+0.76 (+0.51%) ▲|COST986.49+3.76 (+0.38%) ▲|CRM232.91-9.20 (-3.80%) ▼|CSCO109.78-0.51 (-0.46%) ▼|CVS91.12+1.17 (+1.30%) ▲|CVX231.09+1.89 (+0.82%) ▲|DE642.73+2.06 (+0.32%) ▲|DHR235.33+1.26 (+0.54%) ▲|DIS110.41+1.37 (+1.26%) ▲|DUK125.00+1.43 (+1.16%) ▲|EMR169.24+1.53 (+0.91%) ▲|FDX302.21-2.37 (-0.78%) ▼|GD366.11+11.76 (+3.32%) ▲|GE310.12+8.99 (+2.99%) ▲|GEV910.54+32.51 (+3.70%) ▲|GILD162.32+3.12 (+1.96%) ▲|GM83.90+1.42 (+1.72%) ▲|GOOG283.34-38.55 (-11.98%) ▼|GOOGL285.45-39.44 (-12.14%) ▼|GS934.98+9.81 (+1.06%) ▲|HD324.25+6.69 (+2.11%) ▲|HON217.91-1.35 (-0.62%) ▼|IBM253.97+0.75 (+0.30%) ▲|INTC93.11-2.42 (-2.53%) ▼|INTU330.88+2.69 (+0.82%) ▲|ISRG445.80+1.62 (+0.36%) ▲|JNJ274.67+3.63 (+1.34%) ▲|JPM345.18+5.88 (+1.73%) ▲|KO92.45+0.72 (+0.78%) ▲|LIN502.00-6.16 (-1.21%) ▼|LLY1,384.73+96.43 (+7.48%) ▲|LMT642.53+12.78 (+2.03%) ▲|LOW203.16+4.76 (+2.40%) ▲|LRCX258.03+4.21 (+1.66%) ▲|MA638.11+27.80 (+4.55%) ▲|MCD254.90+4.40 (+1.75%) ▲|MDLZ62.04+0.17 (+0.27%) ▲|MDT95.35+0.57 (+0.60%) ▲|META623.57+11.08 (+1.81%) ▲|MMM175.54+2.74 (+1.59%) ▲|MO75.79+2.80 (+3.83%) ▲|MRK146.79+5.86 (+4.15%) ▲|MS192.41+2.28 (+1.20%) ▲|MSFT524.28-6.73 (-1.27%) ▼|MU955.79-27.44 (-2.79%) ▼|NEE81.88+0.86 (+1.06%) ▲|NFLX62.09+0.10 (+0.15%) ▲|NKE38.22+1.07 (+2.88%) ▲|NOW113.63-36.50 (-24.31%) ▼|NVDA213.78-1.60 (-0.74%) ▼|ORCL140.26-4.29 (-2.96%) ▼|PEP133.00+0.37 (+0.28%) ▲|PFE29.69+0.24 (+0.80%) ▲|PG158.87+0.61 (+0.39%) ▲|PLTR195.59-1.22 (-0.62%) ▼|PM205.45+2.81 (+1.39%) ▲|QCOM181.31-1.66 (-0.91%) ▼|RTX199.85+4.01 (+2.05%) ▲|SBUX104.98+1.78 (+1.72%) ▲|SCHW89.71+0.95 (+1.06%) ▲|SO92.70+1.18 (+1.29%) ▲|SPG214.63+3.39 (+1.60%) ▲|T20.70-0.24 (-1.15%) ▼|TMO704.94+0.79 (+0.11%) ▲|TMUS149.97+1.89 (+1.27%) ▲|TSLA403.77-0.45 (-0.11%) ▼|TXN309.83+0.92 (+0.30%) ▲|UBER65.27-0.51 (-0.78%) ▼|UNH407.10-3.29 (-0.80%) ▼|UNP297.80-2.08 (-0.69%) ▼|UPS105.62-0.47 (-0.44%) ▼|USB59.60-0.14 (-0.23%) ▼|V400.60-1.26 (-0.31%) ▼|VZ43.18-0.75 (-1.71%) ▼|WFC83.67+1.01 (+1.22%) ▲|WMT118.77-0.55 (-0.46%) ▼|XOM182.02+2.11 (+1.17%) ▲|
12.9 C
New York
Thursday, October 29, 2026

Tag: pharmaceutical

newsFORsourcecompanycontentinformationreleases1market

Ageless Shoulders Releases 2025 Update on Indian Club Shoulder Exercises and At-Home Frozen Shoulder Mobility Program

In this 2025 release, Ageless Shoulders expands its digital shoulder mobility system using traditional Indian club exercises to support joint flexibility, address frozen shoulder limitations, and meet rising search demand for non-surgical, at-home movement programs. 
In this 2025 release, Ageless Shoulders expands its digital shoulder mobility system using traditional Indian club exercises to support joint flexibility, address frozen shoulder limitations, and meet rising search demand for non-surgical, at-home movement programs.

Centivax Raises Oversubscribed $45 Million Series A Led by Future Ventures to Advance Universal Flu Vaccine into Clinic and Expand Universal Immunity Portfolio

Oversubscribed round was led by Future Ventures, and included NFX, BOLD Capital Partners, Kendall Capital Partners, Amplify Partners, Base4 Capital and others Dr. Emilio Emini, former SVP of...

New Fat Burner for Women Launched Over the Counter – PhenQ Medically Accredited Fat Burning Supplement

Clinicians’ Choice Fat Burner for Women, PhenQ: Clinically Endorsed by 800 Healthcare Professionals Launched Over the Counter in the USA and Worldwide. 
Clinicians’ Choice Fat Burner for Women, PhenQ: Clinically Endorsed by 800 Healthcare Professionals Launched Over the Counter in the USA and Worldwide.

Biotia Partners with Leading Korean Pharmaceutical Company to Advance Infectious Disease Diagnostics in Remote Regions — Including in Space

QUEENS, N.Y., July 8, 2025 /PRNewswire/ -- Biotia, a biotechnology company pioneering the development of novel infectious disease diagnostics, today announced its selection as...

Zuellig Pharma Launches “Obesity is a Disease” Seminar as Part of “Reduce Size, Reduce Disease” Campaign

The campaign aims to enhance the understanding of obesity as a chronic disease and solutions to help manage the disease among Thais and healthcare...

Veeda Lifesciences announces partnership with Mango Sciences to bring AI innovation in clinical trials services

AHMEDABAD, India, July 8, 2025 /PRNewswire/ -- Veeda Lifesciences, a global contract research organization (CRO), has announced an investment in Mango Sciences, a Boston-based...

WuXi AppTec Provides Updates on Q2 Share Repurchase/Acquisition Activities

SHANGHAI, July 7, 2025 /PRNewswire/ -- WuXi AppTec Co., Ltd. (Stock codes: 603259.SH/2359.HK), a global company that provides a broad portfolio of R&D and...

Celltrion USA announces U.S. launch of denosumab biosimilars, STOBOCLO® and OSENVELT® (denosumab-bmwo)

STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of PROLIA® (denosumab) and XGEVA® (denosumab) respectively,STOBOCLO and OSENVELT, among the first...

Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and Eric Huang as Senior Vice President of Global Corporate Development and Finance

ROCKVILLE, Md. and SUZHOU, China, July 07, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced the appointments of Veet Misra, Ph.D., as the Company’s Chief Financial Officer, and Mr. Eric Huang, as Senior Vice President of Global Corporate Development and Finance. Both Dr. Misra and Mr. Huang will report directly to Dajun Yang, M.D., Ph.D., the Company’s Chairman & Chief Executive Officer.

Luma Nutrition Magnesium Glycinate Surpasses 10,000 Monthly Sales on Amazon

Los Angeles, CA , July 07, 2025 (GLOBE NEWSWIRE) -- Luma Nutrition is proud to announce that its flagship product, Luma Nutrition Magnesium Glycinate 1000mg, has officially surpassed 10,000 units sold per month on Amazon. As one of the best magnesium glycinate supplements available in 2025, this high-absorption formula continues to earn praise for its purity, effectiveness, and ability to support restful sleep, mental clarity, and full-body relaxation. 

Ipsen – Half year statement – 2025 06 30

Half-year statement of IPSEN liquidity agreement with NATIXIS ODDO BHF

mRNA Sequencing Market Size to Hit USD 4.02 billion by 2031, Growing at 13.6% CAGR, Benefits from Surging Prevalence of Cancer | The Insight...

NEW YORK, July 7, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global mRNA sequencing market is observing...

Analyzing CEO Insights: Stripe and Skip’s Influence on Algorithmic Market Dynamics

Patrick Collison, CEO of Stripe, and Kathryn Zealand, CEO of Skip, recently joined a discussion focused on the intersection of technology and societal advancement....

National Heart, Lung, and Blood Institute / National Institutes of Health Signs Clinical Trial Agreement with Vascarta Inc. to Perform Phase 1 Clinical Study...

SUMMIT, N.J., July 7, 2025 /PRNewswire/ -- Under the agreement, the National Heart, Lung, and Blood Institute / National Institutes of Health will perform...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPharmaceutical

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers